Nebenwirkungen · Capecitabine Teva
Capecitabine Teva 150 mg film-coated tablets Capecitabine Teva 500 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 13
HOS-215423 · Präparat HOS-155434
Body System Very Common Common Uncommon Rare/Very Rare (Post-Marketing All grades All grades Severe and/or Experience) Life-threatening (grade 3-4) or considered medically relevant Infections and - Herpes viral Sepsis, Urinary infestations infection, tract infection, Nasopharyngitis, Cellulitis, Lower respiratory Tonsillitis, tract infection Pharyngitis, Oral candidiasis, Influenza, Gastroenteritis, Fungal infection, Infection, Tooth abscess Neoplasm benign, - - Lipoma malignant and unspecified Blood and - Neutropenia, Febrile lymphatic system Anaemia neutropenia, disorders Pancytopenia, Granulocytopenia , Thrombocytopeni a, Leukopenia, Haemolytic anaemia, International Normalised Ratio (INR) increased / Prothrombin time prolonged Immune system - - Hypersensitivity Angioedema disorders (rare)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-11T15:40:00Z · SHA-256 360b33238effee7033c9ecfa3731a36e172b67d4837e971f09a6e80d5cda73df · Passage dc419f00e30e2f6e1c1eb7d68ceea36a7e9514724fd91e06343ab77694a6ec0d · Zeichen 2047–4930 im Abschnitt